Protara Therapeutics's market cap is currently ―. The company's EPS TTM is $-3.567; its P/E ratio is -0.77; Protara Therapeutics is scheduled to report earnings on May 2, 2024, and the estimated EPS forecast is $-0.91. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	-	$ 4.00K	-	$ 17.00K	$ 0.00
Gross Profit	-	$ 4.00K	-	$ 17.00K	-
EBIT	$ -9.86M	$ -11.29M	$ -9.04M	$ -39.49M	$ -7.42M
EBITDA	$ -9.88M	$ -11.01M	$ -8.70M	$ -38.97M	$ -6.33M
Net Income Common Stockholders	$ -9.86M	$ -11.29M	$ -9.04M	$ -38.95M	$ -7.69M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 74.03M	$ 80.36M	$ 86.61M	$ 84.37M	$ 96.32M
Total Assets	$ 88.47M	$ 95.14M	$ 106.41M	$ 113.29M	$ 148.59M
Total Debt	$ 5.70M	$ 5.93M	$ 6.16M	$ 6.38M	$ 6.60M
Net Debt	$ -68.33M	$ -74.43M	$ -80.45M	$ -77.99M	$ -89.71M
Total Liabilities	$ 11.51M	$ 9.92M	$ 11.64M	$ 11.21M	$ 9.41M
Stockholders Equity	$ 76.96M	$ 85.22M	$ 94.77M	$ 102.08M	$ 139.18M
Cash Flow	-
Free Cash Flow	$ -6.60M	$ -9.41M	$ -12.89M	$ -5.05M	$ -5.43M
Operating Cash Flow	$ -6.56M	$ -9.41M	$ -12.89M	$ -5.04M	$ -5.35M
Investing Cash Flow	$ 6.38M	$ 22.35M	$ 9.86M	$ -18.34M	$ 19.05M
Financing Cash Flow	$ -27.00K	-	$ -64.00K	-	$ -18.00K

Currency in USD

Protara Therapeutics Earnings and Revenue History

Income Statement >

Protara Therapeutics Debt to Assets

Balance Sheet >

Protara Therapeutics Cash Flow

Cash Flow >

Protara Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing